Fei, B., Zhou, H., He, Z., & Wang, S. (2022). KCNQ1OT1 inhibition alleviates high glucose-induced podocyte injury by adsorbing miR-23b-3p and regulating Sema3A. Clinical and Experimental Nephrology: Official Publication of the Japanese Society of Nephrology, 26(5), 385-397. https://doi.org/10.1007/s10157-021-02173-x
Chicago Style (17th ed.) CitationFei, Bingru, Hui Zhou, Zengjiao He, and Suyu Wang. "KCNQ1OT1 Inhibition Alleviates High Glucose-induced Podocyte Injury by Adsorbing MiR-23b-3p and Regulating Sema3A." Clinical and Experimental Nephrology: Official Publication of the Japanese Society of Nephrology 26, no. 5 (2022): 385-397. https://doi.org/10.1007/s10157-021-02173-x.
MLA (9th ed.) CitationFei, Bingru, et al. "KCNQ1OT1 Inhibition Alleviates High Glucose-induced Podocyte Injury by Adsorbing MiR-23b-3p and Regulating Sema3A." Clinical and Experimental Nephrology: Official Publication of the Japanese Society of Nephrology, vol. 26, no. 5, 2022, pp. 385-397, https://doi.org/10.1007/s10157-021-02173-x.